Search: Andy Krouse
June 17, 2017
A small Charlottesville biopharmaceutical company recently was granted entry to the Nasdaq stock exchange. Diffusion Pharmaceuticals (DFFN) has attracted millions of dollars in private investment to develop cancer drugs from a unique molecule invented at the University of Virginia. The company went public in 2016 to fund its first Phase ...
March 25, 2017
Cavion, a Charlottesville biopharmaceutical company, sent shockwaves through Virginia’s startup scene with a recent announcement that it had raised $26.1 million in Series A venture investment. Andrew Krouse, president and CEO of the company, said securing the funding will help Cavion to achieve a more important goal. “We ...